4//SEC Filing
Bligh James 4
Accession 0001493152-24-046990
CIK 0001896212other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:30 PM ET
Size
5.6 KB
Accession
0001493152-24-046990
Insider Transaction Report
Form 4
Bligh James
DirectorCFO
Transactions
- Award
Stock Option (Right to Buy)
2024-11-18$0.09/sh+1,890,000$173,691→ 1,890,000 totalExercise: $0.09Exp: 2034-11-18→ Common Stock (1,890,000 underlying)
Footnotes (2)
- [F1]Represents Options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan.
- [F2]The Options vest as follows: (i) 50% on the grant date and (ii) 50% in equal annual installments on the first three anniversaries of the grant date.
Documents
Issuer
CONDUIT PHARMACEUTICALS INC.
CIK 0001896212
Entity typeother
Related Parties
1- filerCIK 0001990748
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:30 PM ET
- Size
- 5.6 KB